Top Back to top

Association between uric acid levels and graft-versus-host disease

Study number:
84110032
Type of transplant:
 
Short title:
Uric Acid Study
Study status:
Recruiting / Data Collection
Deadline for data collection:
Study design:
Prospective study
Primary objective:
To assess if uric acid acting as danger signal and released during conditioning therapy is associated with occurence and severity of acute GvHD​
Key inclusion criteria:
First allo-SCT from HLA-matched sibling donors given stem cell grafts (bone marrow or peripheral blood) without T cell depletion, patients with AL, MDS or Lymphoma, Myeloablative and dose-reduced conditioning
Country:
 
Principal investigator:
Olaf Penack
Principal investigator email:
 
EBMT Study coordinator:
Steffie van der Werf

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to data.protection@ebmt.org